Document is current
Any future updates will be listed below
-
Authors
Tribble, James R. http://orcid.org/0000-0001-8301-7358
Hagström, Anna
Jusseaume, Kenza
Lardner, Emma
Wong, Raymond Ching-Bong http://orcid.org/0000-0002-8092-9455
Stålhammar, Gustav
Williams, Pete A. http://orcid.org/0000-0001-6194-8397
-
Funding
Funding for this research was provided by:
Vetenskapsrådet (2018-02124, 2022-00799)
Alcon Research Institute (Young Investigator)
Ögonfonden
National Health and Medical Research Council
Karolinska Institute
- License Information
-
More Information
Article History
Received: 5 December 2022
Accepted: 10 January 2023
First Online: 22 January 2023
Declarations
:
: Access to histopathology archive samples was fully covered through biobank #366 (St Erik Eye Hospital). The study adhered to the tenets of the Declaration of Helsinki and the ethics protocols were approved by the Swedish Ethical Review Authority (2020-01525 and 2021-01036).
: Not applicable.
: PAW is an inventor on an awarded US patent held by The Jackson Laboratory for nicotinamide treatment in glaucoma (“Treatment and prevention of ocular neurodegenerative disorder”, US11389439B2). All other authors declare that they have no competing interests.
